#$%^&*AU2011200423B220121129.pdf#####DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS Abstract The invention relates to methods and compositions for treatment of bacterial 5 infections. The composition may be a combination of factors, which include A0, A], B1, B2 , Co, C1, isoBo, and MAG, in the presence of low level solvent. Methods of the invention include administration of dalbavancin formulations for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimens include multiple dose administration of dalbavancin, which often remains at 10 therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection. Dosing regimens for renal patients are also described.
